<?xml version="1.0" encoding="UTF-8"?>
<ref id="jcp29785-bib-0042">
 <mixed-citation publication-type="journal" id="jcp29785-cit-0042">
  <string-name>
   <surname>Ning</surname>, 
   <given-names>Q.</given-names>
  </string-name>, 
  <string-name>
   <surname>Brown</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Parodo</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Cattral</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gorczynski</surname>, 
   <given-names>R.</given-names>
  </string-name>, 
  <string-name>
   <surname>Cole</surname>, 
   <given-names>E.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Levy</surname>, 
   <given-names>G.</given-names>
  </string-name> (
  <year>1998</year>). 
  <article-title>Ribavirin inhibits viral‐induced macrophage production of TNF, IL‐1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response</article-title>. 
  <source xml:lang="en">The Journal of Immunology</source>, 
  <volume>160</volume>(
  <issue>7</issue>), 
  <fpage>3487</fpage>–
  <lpage>3493</lpage>.
  <pub-id pub-id-type="pmid">9531310</pub-id>
 </mixed-citation>
</ref>
